Sacituzumab Govitecan
Records for this ingredient, by country (identity only).
ATC L01FX17 · 11 markets · 14 records
AU 3 records · 1 shown of 1
- 180 mg per mL / per unit basis not statedinjectionTRODELVYTRODELVY sacituzumab govitecan 180 mg powder for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 1 shown of 1
- 200 mg per mL / per unit basis not statedinjectionTRODELVY
US 1 records · 1 shown of 1
- 180 mgpowderTRODELVY
GB 1 records · 1 shown of 1
- 180 mg per mL / per unit basis not statedinjectionTrodelvy 180mg powder for concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 180 mgpowderTRODELVY
SG 1 records · 1 shown of 1
- 180 mg/vial per mL / per unit basis not statedinjectionTRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 200 mg per mL / per unit basis not statedinjectionTRODELVY 200 mg, poudre pour solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180 mg per mL / per unit basis not stated cannot compare injection | Trodelvy 180mg powder for concentrate for solution for infusion vials | TRODELVY TRODELVY sacituzumab govitecan 180 mg powder for injection vial | |||||||||
| 200 mg per mL / per unit basis not stated cannot compare injection | TRODELVY | TRODELVY 200 mg, poudre pour solution à diluer pour perfusion | |||||||||
| 180 mg powder | TRODELVY | TRODELVY | |||||||||
| 180 mg/vial per mL / per unit basis not stated cannot compare injection | TRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL | ||||||||||
unknown | TRODELVY | TRODELVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 180MG | TRODELVY | ||||||||
injection | TRODELVY for 拓達維注射劑 | ||||||||||
liquid | TRODELVY |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in SG · ES · MX · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en SG · ES · MX · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 SG · ES · MX · FR 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 SG · ES · MX · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.